Brii Biosciences Ltd. held its annual general meeting on June 3, 2025. During the meeting, several proposals were voted on. The proposal to adopt the audited consolidated financial statements for the year ended December 31, 2024, was approved. The re-election of Dr. Ankang Li as an executive Director was also approved. Additionally, Mr. Gregg Huber Alton and Mr. Yiu Wa Alec Tsui were re-elected as independent non-executive Directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.